A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).
Clinical trial NCT02622334 · COMPLETED
Trial details
- NCT number
- NCT02622334
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-29
- Primary completion
- 2016-07-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.